In hypertensive human patients, ESM-1 concentration correlates with the presence and severity of coronary artery disease, and the clinical benefits of ACE inhibitors include lower blood pressure and prevention of cardiovascular disease [35]. Here, ESM1 is linked to cardiovascular disorder.